ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsCherrie K. Donawho, David J. Frost, Joy Bauch et al.|Clinical Cancer Research|2007Cited by 770
Potent and selective inhibitors of Akt kinases slow the progress of tumors <i>in vivo</i>Yan Luo, Vincent L. Giranda, Alexander R. Shoemaker et al.|Molecular Cancer Therapeutics|2005Cited by 244